|
End-of-day quote
Egyptian Exchange
10/09/2026
|
5-day change | 1st Jan Change | ||
| 1.680 EGP | -1.75% |
|
+9.80% | +47.37% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 958M 18.67M 16.08M 15.23M 13.8M 25.89M 1.78B 26.03M 181M 69.55M 907M 70.1M 68.56M 2.87B | P/E 2026 * |
28x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 878M 17.11M 14.74M 13.96M 12.65M 23.74M 1.63B 23.86M 166M 63.76M 832M 64.27M 62.86M 2.63B | EV / Sales 2026 * |
0.74x | EV / Sales 2027 * | 0.55x |
| Free-Float |
30.46% | Yield 2026 * |
1.79% | Yield 2027 * | 2.38% |
| 1 day | -1.75% | ||
| 1 week | +9.80% | ||
| Current month | +12.00% | ||
| 1 month | +6.33% | ||
| 3 months | +38.84% | ||
| 6 months | +21.74% | ||
| Current year | +47.37% |
| 1 week | 1.54 |  | 1.79 |
| 1 month | 1.44 | | 1.79 |
| Current year | 1.02 | | 1.79 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.75% | +9.80% | -49.85% | -35.88% | 18.67M | |
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | |
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | |
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | |
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | |
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | |
| Average | -0.83% | -5.24% | +13.48% | +33.23% | 350.48B | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 23.19M 19.98M 18.92M 17.15M 32.17M 2.22B 32.33M 225M 86.4M 1.13B 87.08M 85.17M 3.56B | 1.55B 30.24M 26.06M 24.67M 22.36M 41.95M 2.89B 42.17M 293M 113M 1.47B 114M 111M 4.64B |
| Net income | 206M 4.01M 3.46M 3.27M 2.97M 5.57M 383M 5.6M 38.89M 14.96M 195M 15.08M 14.74M 616M | 283M 5.51M 4.75M 4.5M 4.08M 7.65M 527M 7.69M 53.43M 20.55M 268M 20.71M 20.26M 847M |
| Net Debt | -79.7M -1.55M -1.34M -1.27M -1.15M -2.15M -148M -2.17M -15.05M -5.79M -75.48M -5.83M -5.7M -239M | -110M -2.14M -1.85M -1.75M -1.58M -2.97M -205M -2.99M -20.77M -7.99M -104M -8.05M -7.87M -329M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | EGP 1.680 | -1.75% | 54,495,672 |
| 09/09/26 | EGP 1.710 | +2.40% | 148,608,400 |
| 08/09/26 | EGP 1.670 | 0.00% | 119,786,157 |
| 07/09/26 | EGP 1.670 | -1.18% | 136,807,962 |
| 06/09/26 | EGP 1.690 | +10.46% | 226,731,621 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.680EGP
Average target price
1.570EGP
Spread / Average Target
-6.55%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
